text:
By Dani Walker
Located in Kamloops, British Columbia, Sean Bulman uses Chief Architect to integrate a client's inspirations into a design that suits both their needs and budget.
Sean Bulman's winning design in our Residential Design Contest (pictured above) was a collaborative effort, combining his design expertise and his client's vision. Sean's design was automatically entered into the 2019 Design of the Year Contest, where he took 1st Place in the Residential Design Category!
Working primarily with custom homes, Sean's designs are heavily influenced by his clients' wants and needs. The Kamloops area has experienced quite a bit of growth in recent years, bringing changes to the local housing market and its aesthetics. Sean describes a shift towards a design mix of Craftsman and modern.
His winning design is contemporary, blended with many elements of the Prairie Style. "It was important to create interest in the form of the home and maximize multiple view corridors from each living space. I strive to integrate a client's inspirations into a home layout that suits their needs and budget. The most important outcome is a happy client, and the only thing that makes a client happier than low cost is making their vision come to life!"
Sean's passion for design started in high school when he enrolled in a design and drafting technologies class. A fire lit, he went on to earn a diploma in Architecture Engineering Technology and a Bachelor's in Building Science both through Thompson Rivers University in Kamloops, B.C.
Sean has been running his business, Bulman Designs, for about 5 years now. In his studies, he learned both CAD and Revit; however, knowing he wanted to focus specifically on residential design, he found himself looking for a software package with tools designed for that task. That's when he discovered Chief Architect X6. "I loved how Chief Architect had the same focus I did for residential design. I had the opportunity to design a home during my time as a framer for a building company in Kamloops. This quickly led me into designing and building my own home in conjunction with starting my business strictly based with Chief Architect."
I think Chief Architect is a large component to my success in design.
Sean uses Chief Architect to make real-time changes during meetings with his clients. If clients are unsure about what they would like, working in Chief Architect gives Sean the ability to showcase various design options while helping them find their design style. "In a few minutes, I can completely change the look and feel of a home right in that meeting. Detail work is required outside of those aesthetic changes to conform to building codes and best practices; but for most clients, it's the look at the end of the day that they care about. I couldn't do that without Chief. Most CAD software is good but the speed and functionality of Chief really blows them out of the water when combined with my on-site experience."
Winning Design
Bulman Designs has been in operation for over 5 years in Kamloops, B.C. Sean has been working with Chief Architect since 2014 and in that time he has designed over 60 custom homes in the Thompson-Okanagan area.
Connect with Sean:


text:
NEW YORK -- You don't see people like him very often, retired Fallsburg Teacher Mike Weiner said of Class of 1991 graduate Matthew Ingber.
"He was a true leader in his class, genuinely cared …
This item is available in full to subscribers.
Please log in to continue |
NEW YORK -- You don't see people like him very often, retired Fallsburg Teacher Mike Weiner said of Class of 1991 graduate Matthew Ingber.
"He was a true leader in his class, genuinely cared about everyone around him and hoped they'd succeed," Weiner continues.
Weiner served as the Class of 1991's advisor. Weiner started coaching at Fallsburg in 1981, and was a teacher at the district from 1985-86 until 2014 when he retired. In that time he's seen a lot of students, but notes that if he had to pick someone as a role model, Ingber would definitely be in the conversation. "He was a great student and community person."
And now, 28 years later, at age 45, Ingber has been named Partner-in-Charge of law firm Mayer Brown's New York Office.
While attending Fallsburg Junior/Senior High School, Ingber played golf, tennis and was on the ski team. He was the president of his class before going to the University of Pennsylvania where he majored in International Relations and minored in economics.
Ingber then attended law school at George Washington University. When he graduated in 1998 he was hired by Mayer Brown where he's worked ever since.
He started as an associate in the New York office, and in about eight years was made partner at the firm in the litigation group, focusing on commercial and securities litigation. He'd go on to chair the office's Pro-Bono committee and helped manage the global litigation group. And now as Partner-in-Charge, Ingber manages the office's approximately 250 lawyers while continuing his own practice, working with clients across the U.S. and internationally.
"I enjoy working on cases where I can learn about different industries or products," Ingber said. "That variety of cases can be challenging but also intellectually stimulating and energizing. Combined with my terrific collegues and clients, that's what continues to draw me into this profession and this firm."
Ingber recently handled a lot of financial crisis litigation, which featured some of the largest institutions in history.
He also enjoys his pro-bono work because he's "representing people who really need legal services and would otherwise be unable to afford it."
In addition to his work at Mayer Brown, Ingber sits on the boards of the NY Lawyers for the Public Interest, Lawyers' Committee for Civil Rights Under Law, and The Cameron Kravitt Foundation.
Ingber currently resides in New York City with his wife Michelle and their daughters Sophie (age 15) and Jordana (age 12). He notes that in his free time he spends as much time with his family as he can. "That's my priority and what's most important to me," he says.
He also enjoys playing tennis, skiing, exercising from time to time, and is very active at his synagogue.
Ingber was one-of-two kids. His sister Melissa, also lives in NYC, and parents, Howie and Fern reside in Middletown.
"He's always been a self-motivator," Fern says. "He's been a joy since he was born, and has given us nothing but pride in everything he's done. He has the biggest heart I've ever known and is the kindest, most giving person on the planet."
His father, Howie, President of Service Scaffold Company, Inc. in South Fallsburg, says, "As busy as he is, he makes time for everyone else. He could be on the other side of the world, and if his kids have a meeting, he'll be there. He's a wonderful, wonderful man."
"I still have a deep connection to Sullivan County," Ingber said. "I'm grateful it's where I was able to grow up."
No comments on this item Please log in to comment by clicking here

subset: commoncrawl


text: Maintaining a healthy diet is crucial for lowering the level of blood pressure; your food affects the possibility of suffering high blood pressure (hypertension). And since following a healthy and balanced diet curbs the risk of low or high blood pressure, it is highly recommended to adopt a heart-friendly diet. Such a diet helps control blood pressure, mitigate the risk of heart attacks, strokes, and other health complications. The blood pressure can be lowered by eating low-fat, low-cholesterol foods, skimmed or low-fat dairy products, and eating more vegetables and fruits. 'DASH' stands for: Dietary Approaches to Stop Hypertension.


text:
Stacy Bair
Position: Forward
Year: Senior
Major: Heath Promotions
Hometown: Richmond, UT
Morgan Quarnberg
Position: Forward
Year: Freshman
Major: Business
Hometown: Pleasant Grove, UT
This week, two forwards from the Women's soccer team share the title of athlete of the week.
Senior Stacy Bair is starting what will be her final season as a Wildcat and has played in 53 games leading up to this season, while starting in 35 of those games. As a player up to this season, she has shot 40 of 89 shots on frame for a .449 shot on goal percentage and has netted 11 goals and seven assists on her career leading up to this season.
This past week, she was named the HERO sports Division I Gem of the Week for her performance in the Sept. 4 game versus New Mexico State where Bair notched three assists for the team in the 3-0 defeat of NMSU. This made Bair the first player in 10 years to earn three consecutive assists in one game.
Freshman Morgan Quarnberg currently leads the team with three goals on the season, two of which were netted in there most recent home game against Colorado College. She has bee an offensive force for the Wildcats with 5 of 6 shots on goal for an SOG percentage of .833, leading all scorers on the team.
The women will play again Sept. 18 as they host Loyola Marymount. The game will kick off at 3 p.m.


text:
The Russian Defence Ministry has published a video of an RSM-56 Bulava missile being launched from the K-535 Yury Dolgoruky Borei-class submarine.
The test-launch, which took place in the Barents Sea, was described as successful after the missile destroyed its target.
The R-30 Bulava is a solid-fuel ballistic missile developed expressly for Project 955 submarines. It carries 10 warheads of 150 kilotons each and has a range of 8,000 kilometres (5,000 miles).


text:
If you want to apply for our KREW program, fill out our application form here.
Our PATH projects KREW is a group of passionate runners that are actively involved in the outdoor space. From adventurers, running coaches and podcast hosts, to race directors, volunteers and group run leaders, they all push themselves and test new limits.
Each member has their own page on our website, to learn more about them, their race accomplishments they are proud of, their favorite PATH projects gear and more. See links to each profile below.


text:
Saudi Industrial Property Authority allocated SR 9 billion ($ 2.4 billion) to upgrade
services, infrastructure and support services in 33 industrial properties. With 2551
operating factories and 500 under construction, the total investments amount to SR 150
billion ($ 40 billion). 300 prefabricated factories have been established for small and
medium size businesses while 2000 will be established during the next two years to
provide industrial incubators for young entrepreneurs.
Last Modified Date: 04/06/2014 - 2:03 PM Saudi Arabia Time


text: Our hotel in London was just around the corner from the British Museum and therefore we were able to call in to what is one of the finest museum's in the world. And there are few finer feelings than walking through those grand doors - without charge, without let, and without hindrance. The former inner courtyard has been covered with a fine roof creating a wonderful space. Surely this must be one of the best Millennium projects in the country.


text:
Opened 12 years ago Closed 11 years ago #687 closed defect (fixed)Missing clip in 8.6.5 Picture construction process prior to in-loop filter process?
In section 8.6.5 on "Picture construction process prior to in-loop filter process", either Inter or Intra predicted samples are added to residual samples to form reconstructed samples.
This process does not clip the reconstructed samples to be in the range 0 to (1<<BitDepth)-1. I can't see any subsequent stage which would clip the samples (where in-loop filter may not modify the samples) to ensure the reconstructed frames are clipped to the correct precision.
In the HM software, in TDecCu.cpp, for Inter data the function 'xReconInter' uses 'addClip' function, and for Intra data 'xReconIntraQT' calls 'xIntraLumaRecQT', which calls 'xIntraRecLumaBlk', which clips the luma samples (there is a similar function for chroma).
Unless I've a missed a clip operation somewhere else in the text, I beleive section 8.6.5 should be modified as follows;-
Depending on the colour component cIdx, the following assignments are made.
The (nS)x(nS) block of the reconstructed sample array recSamples at location ( xB, yB ) is derived as follows. Change History (7)comment:1 Changed 12 years ago by DefaultCC Plugin
comment:2 Changed 11 years ago by bbross
Ticket #807 has been marked as a duplicate of this ticket. comment:3 Changed 11 years ago by bbross
Ticket #836 has been marked as a duplicate of this ticket. comment:4 Changed 11 years ago by bbross
comment:5 Changed 11 years ago by bbross
comment:6 Changed 11 years ago by bbross
comment:7 Changed 11 years ago by bbross
This has been fixed in JCTVC-K1003_v11. Note: See
TracTickets for help on using
tickets. | This list contains all users that will be notified about changes made to this ticket. These roles will be notified: Reporter, Owner, Subscriber, Participant


text:
- Anti-hestaminic & Respiratory Drugs (14)
- Anti-inflammatory Drugs (130)
- Baby & Mom (1115) +-
- Baby & Mom > Bath, skin & Hair > Skin Care > wibes (47)
- Beauty (2387) +-
- Beauty > Skin Care > whitening (230)
- Chemotherapy & Immune Response (253) +-
- Chemotherapy & Immune Response > ANTI-FUNGAL (2)
- Chemotherapy & Immune Response > Chemotherapeutic Agents > Hormone Antagonists >Enzyme Inhibitors (82)
- Diet & Fitness Products (186) +-
- Drugs affecting CNS >Anti- epileptic (46)
Medical Supplies (445)
- Chemicals & Disinfectants (18)
- Dental Supplies (31)
- Devices & Instruments (7)
- Diabetic Supplies (91)
- General Medical Supplies (21)
- I.V & Medical Solution (0)
- Intensive Care Unit & Anesthesia Supplies (0)
- Kindney Unit Supplies (13)
- Lab Supplies (1)
- Miscellaneous (22)
- Neonatal Unit Supplies (0)
- Operation Room Supplies (4)
- Sanitary (5)
- Sterilization Supplies (0)
- Surgical Sutures (4)
- Syringes (2)
Medicines & Health (2159)
- Allergy & Sinus (84)
- Children's Health Care (46)
- Cough, Cold & Flu (256)
- Digestive Health & Nausea (178)
- Ear, Nose & Throat Care (148)
- Eye Care (102)
- Feminine Care (282)
- Foot Care (3)
- Orthopaedic Appliances (0)
- Pain Relief & Management (179)
- Pill Organizer (0)
- Skin Treatments (633)
- Sleep & Snoring Aids (0)
- Support & Braces (7)
- Medicines & health > Gout releif (34)
- Natural & Organic Products (58) +-
- OTC > Analgesics > Anti-inflammatory Drugs (31)
Personal Care (2684)
- Bath & Body (214)
- Deodorant & Anti-perspirants (159)
- Ear, Nose & Throat Care (141)
- Eye Care (108)
- Feminine Care (316)
- Foot Care (10)
- Hair Care (346)
- Home Tests & Monitorings (14)
- Incontinence (7)
- Lip Care (19)
- Massage & Relaxation (14)
- Natural & Organic Personal Care (6)
- Oral Care (76)
- Pregnancy & Fertility (50)
- Shaving & Grooming (55)
- Sun Care (52)
- Prescribtion drugs > cardiovascular system > Hypertention drugs (201)
Prescription Drugs (2139)
- Analgesics (148)
- Cardiovascular System (269)
- Drugs Affecting CNS (155)
- Drugs Affecting Musculoskeletal System (46)
- Drugs Used In Infections (28)
- Ear & Nose Drugs (2)
- Endocrine System (124)
- Gastrointestinal Tract (178)
- Gastrointestinal Tract (165)
- Miscellaneous (2)
- Nutrients & Blood Electrolytes (0)
- Obstetric & Gynaecology Disorders (1)
- Respiratory System (95)
- Topical Preparations (21)
- Urinary Tract Disorders (12)
- Vaccines (0)
- Prescription Drugs > Cardiovascular System > Anti-hypertensive drugs > Duiretics > Loop duiretics (41)
- prescription drugs > cardiovascular system >Anti-hypertensive drugs > duiretics > Aldosterone antagonist duiretics (62)
- prescription drugs > cardiovascular system >Anti-hypertensive drugs > duiretics > duiretic combinations (59)
- prescription drugs > cardiovascular system >Anti-hypertensive drugs > duiretics > loop duiretics (59)
- Prescription Drugs > Gastrointestinal Tract > Liver treatment (46)
- Sexual Wellness (163) +-
- strong anti-emetic & adjuvent used with anti-neoplastic (1)
- Vitamins & Minerals Supplements (390)
- Vitamins & Supplements> folic acid (1589) +-
Ex Tax: 331EGP
You can return the product within 14 days of purchase.
ReturnsYou can return the product within 14 days of purchase.
Abilify 15 mg ( Aripiprazole ) 10 tablets
1. Name of the medicinal product
ABILIFY 5 mg tablets
ABILIFY 10 mg tablets
ABILIFY 15 mg tablets
4. Clinical particulars
4.1 Therapeutic indications
ABILIFY is indicated for the treatment of schizophrenia in adults and in adolescents aged 15 years and older.
ABILIFY is indicated for the treatment of moderate to severe manic episodes in Bipolar I Disorder and for the prevention of a new manic episode in adults who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment (see section 5.1).
ABILIFY is indicated for the treatment up to 12 weeks of moderate to severe manic episodes in Bipolar I Disorder in adolescents aged 13 years and older (see section 5.1).
4.2 Posology and method of administration
Schizophrenia: the recommended starting dose for ABILIFY is 10 mg/day or 15 mg/day with a maintenance dose of 15 mg/day administered on a once-a-day schedule without regard to meals. ABILIFY is effective in a dose range of 10 mg/day to 30 mg/day. Enhanced efficacy at doses higher than a daily dose of 15 mg has not been demonstrated although individual patients may benefit from a higher dose. The maximum daily dose should not exceed 30 mg.
Manic episodes in Bipolar I Disorder: the recommended starting dose for ABILIFY is 15 mg administered on a once-a-day schedule without regard to meals as monotherapy or combination therapy (see section 5.1). Some patients may benefit from a higher dose. The maximum daily dose should not exceed 30 mg.
Recurrence prevention of manic episodes in Bipolar I Disorder: for preventing recurrence of manic episodes in patients, who have been receiving aripiprazole as monotherapy or combination therapy, continue therapy at the same dose. Adjustments of daily dosage, including dose reduction should be considered on the basis of clinical status.
Paediatric population
Schizophrenia in adolescents aged 15 years and older: the recommended dose for ABILIFY is 10 mg/day administered on a once-a-day schedule without regard to meals. Treatment should be initiated at 2 mg (using ABILIFY oral solution 1 mg/mL) for 2 days, titrated to 5 mg for 2 additional days to reach the recommended daily dose of 10 mg. When appropriate, subsequent dose increases should be administered in 5 mg increments without exceeding the maximum daily dose of 30 mg (see section 5.1). ABILIFY is effective in a dose range of 10 mg/day to 30 mg/day. Enhanced efficacy at doses higher than a daily dose of 10 mg has not been demonstrated although individual patients may benefit from a higher dose.
ABILIFY is not recommended for use in patients with schizophrenia below 15 years of age due to insufficient data on safety and efficacy (see sections 4.8 and 5.1).
Manic episodes in Bipolar I Disorder in adolescents aged 13 years and older: the recommended dose for ABILIFY is 10 mg/day administered on a once-a-day schedule without regard to meals. Treatment should be initiated at 2 mg (using ABILIFY oral solution 1 mg/mL) for 2 days, titrated to 5 mg for 2 additional days to reach the recommended daily dose of 10 mg. The treatment duration should be the minimum necessary for symptom control and must not exceed 12 weeks. Enhanced efficacy at doses higher than a daily dose of 10 mg has not been demonstrated, and a daily dose of 30 mg is associated with a substantially higher incidence of significant adverse reactions including EPS related events, somnolence, fatigue and weight gain (see section 4.8). Doses higher than 10 mg/day should therefore only be used in exceptional cases and with close clinical monitoring (see sections 4.4, 4.8 and 5.1). Younger patients are at increased risk of experiencing adverse events associated with aripiprazole. Therefore, ABILIFY is not recommended for use in patients below 13 years of age (see sections 4.8 and 5.1).
Irritability associated with autistic disorder: the safety and efficacy of ABILIFY in children and adolescents aged below 18 years have not yet been established. Currently available data are described in section 5.1 but no recommendation on a posology can be made.
Tics associated with Tourette's disorder: the safety and efficacy of ABILIFY in children and adolescents 6 to 18 years of age have not yet been established. Currently available data are described in section 5.1 but no recommendation on a posology can be made.
Special population
Hepatic impairment
No dosage adjustment is required for patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the data available are insufficient to establish recommendations. In these patients dosing should be managed cautiously. However, the maximum daily dose of 30 mg should be used with caution in patients with severe hepatic impairment (see section 5.2).
Renal impairment
No dosage adjustment is required in patients with renal impairment.
The safety and efficacy of ABILIFY in the treatment of schizophrenia or manic episodes in Bipolar I Disorder in patients aged 65 years and older has not been established. Owing to the greater sensitivity of this population, a lower starting dose should be considered when clinical factors warrant (see section 4.4).
No dosage adjustment is required for female patients as compared to male patients (see section 5.2).
Smoking status
According to the metabolic pathway of aripiprazole no dosage adjustment is required for smokers (see section 4.5).
Dose adjustments due to interactions
When concomitant administration of strong CYP3A4 or CYP2D6 inhibitors with aripiprazole occurs, the aripiprazole dose should be reduced. When the CYP3A4 or CYP2D6 inhibitor is withdrawn from the combination therapy, aripiprazole dose should then be increased (see section 4.5).
When concomitant administration of strong CYP3A4 inducers with aripiprazole occurs, the aripiprazole dose should be increased. When the CYP3A4 inducer is withdrawn from the combination therapy, the aripiprazole dose should then be reduced to the recommended dose (see section 4.5).
Method of administration
ABILIFY is for oral use.
Orodispersible tablets or oral solution may be used as an alternative to ABILIFY tablets for patients who have difficulty swallowing ABILIFY tablets (see section 5.2).
4.3 Contraindications
Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
4.4 Special warnings and precautions for use
During antipsychotic treatment, improvement in the patient's clinical condition may take several days to some weeks. Patients should be closely monitored throughout this period.
The occurrence of suicidal behaviour is inherent in psychotic illnesses and mood disorders and in some cases has been reported early after initiation or switch of antipsychotic treatment, including treatment with aripiprazole (see section 4.8). Close supervision of high-risk patients should accompany antipsychotic treatment.
Cardiovascular disorders
Aripiprazole should be used with caution in patients with known cardiovascular disease (history of myocardial infarction or ischaemic heart disease, heart failure, or conduction abnormalities), cerebrovascular disease, conditions which would predispose patients to hypotension (dehydration, hypovolemia, and treatment with antihypertensive medicinal products) or hypertension, including accelerated or malignant. Cases of venous thromboembolism (VTE) have been reported with antipsychotic medicinal products. Since patients treated with antipsychotics often present with acquired risk factors for VTE, all possible risk factors for VTE should be identified before and during treatment with aripiprazole and preventive measures undertaken.
QT prolongation
In clinical trials of aripiprazole, the incidence of QT prolongation was comparable to placebo. Aripiprazole should be used with caution in patients with a family history of QT prolongation (see section 4.8).
Tardive dyskinesia
In clinical trials of one year or less duration, there were uncommon reports of treatment emergent dyskinesia during treatment with aripiprazole. If signs and symptoms of tardive dyskinesia appear in a patient on aripiprazole, dose reduction or discontinuation should be considered (see section 4.8). These symptoms can temporally deteriorate or can even arise after discontinuation of treatment.
Other extrapyramidal symptoms
In paediatric clinical trials of aripiprazole akathisia and Parkinsonism were observed. If signs and symptoms of other EPS appear in a patient taking aripiprazole, dose reduction and close clinical monitoring should be considered.
Neuroleptic Malignant Syndrome (NMS)
NMS is a potentially fatal symptom complex associated with antipsychotics. In clinical trials, rare cases of NMS were reported during treatment with aripiprazole. Clinical manifestations of NMS are hyperpyrexia, muscle rigidity, altered mental status and evidence of autonomic instability (irregular pulse or blood pressure, tachycardia, diaphoresis and cardiac dysrhythmia). Additional signs may include elevated creatine phosphokinase, myoglobinuria (rhabdomyolysis), and acute renal failure. However, elevated creatine phosphokinase and rhabdomyolysis, not necessarily in association with NMS, have also been reported. If a patient develops signs and symptoms indicative of NMS, or presents with unexplained high fever without additional clinical manifestations of NMS, all antipsychotics, including aripiprazole, must be discontinued.
In clinical trials, uncommon cases of seizure were reported during treatment with aripiprazole. Therefore, aripiprazole should be used with caution in patients who have a history of seizure disorder or have conditions associated with seizures (see section 4.8).
Elderly patients with dementia-related psychosis
Increased mortality
In three placebo-controlled trials (n = 938; mean age: 82.4 years; range: 56 to 99 years) of aripiprazole in elderly patients with psychosis associated with Alzheimer's disease, patients treated with aripiprazole were at increased risk of death compared to placebo. The rate of death in aripiprazole-treated patients was 3.5 % compared to 1.7 % in the placebo group. Although the causes of deaths were varied, most of the deaths appeared to be either cardiovascular (e.g. heart failure, sudden death) or infectious (e.g. pneumonia) in nature (see section 4.8).
Cerebrovascular adverse reactions
In the same trials, cerebrovascular adverse reactions (e.g. stroke, transient ischaemic attack), including fatalities, were reported in patients (mean age: 84 years; range: 78 to 88 years). Overall, 1.3 % of aripiprazole-treated patients reported cerebrovascular adverse reactions compared with 0.6 % of placebo-treated patients in these trials. This difference was not statistically significant. However, in one of these trials, a fixed-dose trial, there was a significant dose response relationship for cerebrovascular adverse reactions in patients treated with aripiprazole (see section 4.8).
Aripiprazole is not indicated for the treatment of patients with dementia-related psychosis.
Hyperglycaemia and diabetes mellitus
Hyperglycaemia, in some cases extreme and associated with ketoacidosis or hyperosmolar coma or death, has been reported in patients treated with atypical antipsychotics, including aripiprazole. Risk factors that may predispose patients to severe complications include obesity and family history of diabetes. In clinical trials with aripiprazole, there were no significant differences in the incidence rates of hyperglycaemia-related adverse reactions (including diabetes) or in abnormal glycaemia laboratory values compared to placebo. Precise risk estimates for hyperglycaemia-related adverse reactions in patients treated with aripiprazole and with other atypical antipsychotics are not available to allow direct comparisons. Patients treated with any antipsychotics, including aripiprazole, should be observed for signs and symptoms of hyperglycaemia (such as polydipsia, polyuria, polyphagia and weakness) and patients with diabetes mellitus or with risk factors for diabetes mellitus should be monitored regularly for worsening of glucose control (see section 4.8).
Hypersensitivity reactions, characterised by allergic symptoms, may occur with aripiprazole (see section 4.8).
Weight gain
Weight gain is commonly seen in schizophrenic and bipolar mania patients due to co-morbidities, use of antipsychotics known to cause weight gain, poorly managed life-style, and might lead to severe complications. Weight gain has been reported post-marketing among patients prescribed aripiprazole. When seen, it is usually in those with significant risk factors such as history of diabetes, thyroid disorder or pituitary adenoma. In clinical trials aripiprazole has not been shown to induce clinically relevant weight gain in adults (see section 5.1). In clinical trials of adolescent patients with bipolar mania, aripiprazole has been shown to be associated with weight gain after 4 weeks of treatment. Weight gain should be monitored in adolescent patients with bipolar mania. If weight gain is clinically significant, dose reduction should be considered (see section 4.8).
Oesophageal dysmotility and aspiration have been associated with the use of antipsychotics, including aripiprazole. Aripiprazole should be used cautiously in patients at risk for aspiration pneumonia.
Pathological gambling and other impulse control disorders
Patients can experience increased urges, particularly for gambling, and the inability to control these urges while taking aripiprazole. Other urges, reported, include: increased sexual urges, compulsive shopping, binge or compulsive eating, and other impulsive and compulsive behaviours. It is important for prescribers to ask patients or their caregivers specifically about the development of new or increased gambling urges, sexual urges, compulsive shopping, binge or compulsive eating, or other urges while being treated with aripiprazole. It should be noted that impulse-control symptoms can be associated with the underlying disorder; however, in some cases, urges were reported to have stopped when the dose was reduced or the medication was discontinued. Impulse control disorders may result in harm to the patient and others if not recognised. Consider dose reduction or stopping the medication if a patient develops such urges while taking aripiprazole (see section 4.8).
ABILIFY tablets contain lactose. Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose-galactose malabsorption should not take this medicinal product.
Patients with attention deficit hyperactivity disorder (ADHD) comorbidity
Despite the high comorbidity frequency of Bipolar I Disorder and ADHD, very limited safety data are available on concomitant use of aripiprazole and stimulants; therefore, extreme caution should be taken when these medicinal products are co-administered.
Aripiprazole may cause somnolence, postural hypotension, motor and sensory instability, which may lead to falls. Caution should be taken when treating patients at higher risk, and a lower starting dose should be considered (e.g., elderly or debilitated patients; see section 4.2).
4.5 Interaction with other medicinal products and other forms of interaction
Due to its α1-adrenergic receptor antagonism, aripiprazole has the potential to enhance the effect of certain antihypertensive medicinal products.
Given the primary CNS effects of aripiprazole, caution should be used when aripiprazole is administered in combination with alcohol or other CNS medicinal products with overlapping adverse reactions such as sedation (see section 4.8).
If aripiprazole is administered concomitantly with medicinal products known to cause QT prolongation or electrolyte imbalance, caution should be used.
Potential for other medicinal products to affect aripiprazole
A gastric acid blocker, the H2 antagonist famotidine, reduces aripiprazole rate of absorption but this effect is deemed not clinically relevant. Aripiprazole is metabolised by multiple pathways involving the CYP2D6 and CYP3A4 enzymes but not CYP1A enzymes. Thus, no dosage adjustment is required for smokers.
Quinidine and other CYP2D6 inhibitors
In a clinical trial in healthy subjects, a strong inhibitor of CYP2D6 (quinidine) increased aripiprazole AUC by 107 %, while Cmax was unchanged. The AUC and Cmax of dehydro-aripiprazole, the active metabolite, decreased by 32 % and 47 %, respectively. Aripiprazole dose should be reduced to approximately one-half of its prescribed dose when concomitant administration of aripiprazole with quinidine occurs. Other strong inhibitors of CYP2D6, such as fluoxetine and paroxetine, may be expected to have similar effects and similar dose reductions should therefore be applied.
Ketoconazole and other CYP3A4 inhibitors
In a clinical trial in healthy subjects, a strong inhibitor of CYP3A4 (ketoconazole) increased aripiprazole AUC and Cmax by 63 % and 37 %, respectively. The AUC and Cmax of dehydro-aripiprazole increased by 77 % and 43 %, respectively. In CYP2D6 poor metabolisers, concomitant use of strong inhibitors of CYP3A4 may result in higher plasma concentrations of aripiprazole compared to that in CYP2D6 extensive metabolizers. When considering concomitant administration of ketoconazole or other strong CYP3A4 inhibitors with aripiprazole, potential benefits should outweigh the potential risks to the patient. When concomitant administration of ketoconazole with aripiprazole occurs, aripiprazole dose should be reduced to approximately one-half of its prescribed dose. Other strong inhibitors of CYP3A4, such as itraconazole and HIV protease inhibitors may be expected to have similar effects and similar dose reductions should therefore be applied (see section 4.2). Upon discontinuation of the CYP2D6 or CYP3A4 inhibitor, the dosage of aripiprazole should be increased to the level prior to the initiation of the concomitant therapy. When weak inhibitors of CYP3A4 (e.g. diltiazem) or CYP2D6 (e.g. escitalopram) are used concomitantly with aripiprazole, modest increases in plasma aripiprazole concentrations may be expected.
Carbamazepine and other CYP3A4 inducers
Following concomitant administration of carbamazepine, a strong inducer of CYP3A4, and oral aripiprazole to patients with schizophrenia or schizoaffective disorder, the geometric means of Cmax and AUC for aripiprazole were 68 % and 73 % lower, respectively, compared to when aripiprazole (30 mg) was administered alone. Similarly, for dehydro-aripiprazole the geometric means of Cmax and AUC after carbamazepine co-administration were 69 % and 71 % lower, respectively, than those following treatment with aripiprazole alone. Aripiprazole dose should be doubled when concomitant administration of aripiprazole occurs with carbamazepine. Concomitant administration of aripiprazole and other inducers of CYP3A4 (such as rifampicin, rifabutin, phenytoin, phenobarbital, primidone, efavirenz, nevirapine and St. John's Wort) may be expected to have similar effects and similar dose increases should therefore be applied. Upon discontinuation of strong CYP3A4 inducers, the dosage of aripiprazole should be reduced to the recommended dose.
Valproate and lithium
When either valproate or lithium was administered concomitantly with aripiprazole, there was no clinically significant change in aripiprazole concentrations and therefore no dose adjustment is necessary when either valproate or lithium is administered with aripiprazole.
Potential for aripiprazole to affect other medicinal products
In clinical studies, 10 mg/day to 30 mg/day doses of aripiprazole had no significant effect on the metabolism of substrates of CYP2D6 (dextromethorphan/3-methoxymorphinan ratio), CYP2C9 (warfarin), CYP2C19 (omeprazole), and CYP3A4 (dextromethorphan). Additionally, aripiprazole and dehydro-aripiprazole did not show potential for altering CYP1A2-mediated metabolism in vitro. Thus, aripiprazole is unlikely to cause clinically important medicinal product interactions mediated by these enzymes.
When aripiprazole was administered concomitantly with either valproate, lithium or lamotrigine, there was no clinically important change in valproate, lithium or lamotrigine concentrations.
Serotonin syndrome
Cases of serotonin syndrome have been reported in patients taking aripiprazole, and possible signs and symptoms for this condition can occur especially in cases of concomitant use with other serotonergic medicinal products, such as selective serotonin reuptake inhibitor/selective serotonin noradrenalin reuptake inhibitor (SSRI/SNRI), or with medicinal products that are known to increase aripiprazole concentrations (see section 4.8).
4.6 Fertility, pregnancy and lactation
There are no adequate and well-controlled trials of aripiprazole in pregnant women. Congenital anomalies have been reported; however, causal relationship with aripiprazole could not be established. Animal studies could not exclude potential developmental toxicity (see section 5.3). Patients must be advised to notify their physician if they become pregnant or intend to become pregnant during treatment with aripiprazole. Due to insufficient safety information in humans and concerns raised by animal reproductive studies, this medicinal product should not be used in pregnancy unless the expected benefit clearly justifies the potential risk to the foetus.
Newborn infants exposed to antipsychotics (including aripiprazole) during the third trimester of pregnancy are at risk of adverse reactions including extrapyramidal and/or withdrawal symptoms that may vary in severity and duration following delivery. There have been reports of agitation, hypertonia, hypotonia, tremor, somnolence, respiratory distress, or feeding disorder. Consequently, newborn infants should be monitored carefully (see section 4.8).
Aripiprazole/metabolites are excreted in human milk. A decision must be made whether to discontinue breast-feeding or to discontinue/abstain from aripiprazole therapy taking into account the benefit of breast-feeding for the child and the benefit of therapy for the woman.
Aripiprazole did not impair fertility based on data from reproductive toxicity studies.
4.7 Effects on ability to drive and use machines
Aripiprazole has minor to moderate influence on the ability to drive and use machines due to potential nervous system and visual effects, such as sedation, somnolence, syncope, vision blurred, diplopia (see section 4.8).
4.8 Undesirable effects
Summary of the safety profile
The most commonly reported adverse reactions in placebo-controlled trials were akathisia and nausea each occurring in more than 3 % of patients treated with oral aripiprazole.
Tabulated list of adverse reactions
The incidences of the Adverse Drug Reactions (ADRs) associated with aripiprazole therapy are tabulated below. The table is based on adverse events reported during clinical trials and/or post-marketing use.
All ADRs are listed by system organ class and frequency; very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 to < 1/100), rare (≥ 1/10,000 to < 1/1,000), very rare (< 1/10,000) and not known (cannot be estimated from the available data). Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
The frequency of adverse reactions reported during post-marketing use cannot be determined as they are derived from spontaneous reports. Consequently, the frequency of these adverse events is qualified as "not known".
Not known
Blood and lymphatic system disorders
Immune system disorders
Allergic reaction (e.g. anaphylactic reaction, angioedema including swollen tongue, tongue oedema, face oedema, pruritus allergic, or urticaria)
Endocrine disorders
Diabetic hyperosmolar coma
Diabetic ketoacidosis
Metabolism and nutrition disorders
Diabetes mellitus
Psychiatric disorders
Suicide attempt, suicidal ideation and completed suicide (see section 4.4)
Pathological gambling
Impulse-control disorder
Binge eating
Compulsive shopping
Nervous system disorders
Extrapyramidal disorder
Tardive dyskinesia
Neuroleptic Malignant Syndrome
Grand mal convulsion
Serotonin syndrome
Speech disorder
Eye disorders
Vision blurred
Oculogyric crisis
Cardiac disorders
Sudden death unexplained
Torsades de pointes
Ventricular arrhythmia
Cardiac arrest
Vascular disorders
Orthostatic hypotension
Venous thromboembolism (including pulmonary embolism and deep vein thrombosis)
Respiratory, thoracic and mediastinal disorders
Aspiration pneumonia
Oropharyngeal spasm
Gastrointestinal disorders
Salivary hypersecretion
Abdominal discomfort
Stomach discomfort
Hepatobiliary disorders
Hepatic failure
Skin and subcutaneous tissue disorders
Photosensitivity reaction
Musculoskeletal and connective tissue disorders
Renal and urinary disorders
Urinary incontinence
Urinary retention
Pregnancy, puerperium and perinatal conditions
Drug withdrawal syndrome neonatal (see section 4.6)
Reproductive system and breast disorders
General disorders and administration site conditions
Temperature regulation disorder (e.g. hypothermia, pyrexia)
Chest pain
Peripheral oedema
Weight decreased
Weight gain
Alanine Aminotransferase increased
Aspartate Aminotransferase increased
Gamma-glutamyltransferase increased
Alkaline phosphatase increased
QT prolonged
Blood glucose increased
Glycosylated haemoglobin increased
Blood glucose fluctuation
Creatine phosphokinase increased
Description of selected adverse reactions
Extrapyramidal symptoms (EPS)
Schizophrenia: in a long-term 52-week controlled trial, aripiprazole-treated patients had an overall-lower incidence (25.8 %) of EPS including Parkinsonism, akathisia, dystonia and dyskinesia compared with those treated with haloperidol (57.3 %). In a long-term 26-week placebo-controlled trial, the incidence of EPS was 19 % for aripiprazole-treated patients and 13.1 % for placebo-treated patients. In another long-term 26-week controlled trial, the incidence of EPS was 14.8 % for aripiprazole-treated patients and 15.1 % for olanzapine-treated patients.
Manic episodes in Bipolar I Disorder: in a 12-week controlled trial, the incidence of EPS was 23.5 % for aripiprazole-treated patients and 53.3 % for haloperidol-treated patients. In another 12-week trial, the incidence of EPS was 26.6 % for patients treated with aripiprazole and 17.6 % for those treated with lithium. In the long-term 26-week maintenance phase of a placebo-controlled trial, the incidence of EPS was 18.2 % for aripiprazole-treated patients and 15.7 % for placebo-treated patients.
In placebo-controlled trials, the incidence of akathisia in bipolar patients was 12.1 % with aripiprazole and 3.2 % with placebo. In schizophrenia patients the incidence of akathisia was 6.2 % with aripiprazole and 3.0 % with placebo.
Class effect: Symptoms of dystonia, prolonged abnormal contractions of muscle groups, may occur in susceptible individuals during the first few days of treatment. Dystonic symptoms include: spasm of the neck muscles, sometimes progressing to tightness of the throat, swallowing difficulty, difficulty breathing, and/or protrusion of the tongue. While these symptoms can occur at low doses, they occur more frequently and with greater severity with high potency and at higher doses of first generation antipsychotic medicinal products. An elevated risk of acute dystonia is observed in males and younger age groups.
In clinical trials for the approved indications and post-marketing, both increase and decrease in serum prolactin as compared to baseline was observed with aripiprazole (section 5.1).
Laboratory parameters
Comparisons between aripiprazole and placebo in the proportions of patients experiencing potentially clinically significant changes in routine laboratory and lipid parameters (see section 5.1) revealed no medically important differences. Elevations of CPK (Creatine Phosphokinase), generally transient and asymptomatic, were observed in 3.5 % of aripiprazole treated patients as compared to 2.0 % of patients who received placebo.
Paediatric population
Schizophrenia in adolescents aged 15 years and older
In a short-term placebo-controlled clinical trial involving 302 adolescents (13 to 17 years) with schizophrenia, the frequency and type of adverse reactions were similar to those in adults except for the following reactions that were reported more frequently in adolescents receiving aripiprazole than in adults receiving aripiprazole (and more frequently than placebo):
Somnolence/sedation and extrapyramidal disorder were reported very commonly (≥ 1/10), and dry mouth, increased appetite, and orthostatic hypotension were reported commonly (≥ 1/100, < 1/10). The safety profile in a 26-week open-label extension trial was similar to that observed in the short-term, placebo-controlled trial.
The safety profile of a long-term, double-blind, placebo-controlled trial was also similar except for the following reactions that were reported more frequently than paediatric patients taking placebo: weight decreased, blood insulin increased, arrhythmia, and leukopenia were reported commonly (≥ 1/100, < 1/10).
In the pooled adolescent schizophrenia population (13 to 17 years) with exposure up to 2 years, incidence of low serum prolactin levels in females (< 3 ng/mL) and males (< 2 ng/mL) was 29.5 % and 48.3 %, respectively. In the adolescent (13 to 17 years) schizophrenia population with aripiprazole exposure of 5 mg to 30 mg up to 72 months, incidence of low serum prolactin levels in females (< 3 ng/mL) and males (< 2 ng/mL) was 25.6 % and 45.0 %, respectively.
In two long-term trials with adolescent (13 to 17 years) schizophrenia and bipolar patients treated with aripiprazole, incidence of low serum prolactin levels in females (< 3 ng/mL) and males (< 2 ng/mL) was 37.0 % and 59.4 %, respectively.
Manic episodes in Bipolar I Disorder in adolescents aged 13 years and older
The frequency and type of adverse reactions in adolescents with Bipolar I Disorder were similar to those in adults except for the following reactions: very commonly (≥ 1/10) somnolence (23.0 %), extrapyramidal disorder (18.4 %), akathisia (16.0 %), and fatigue (11.8 %); and commonly (≥ 1/100, < 1/10) abdominal pain upper, heart rate increased, weight increased, increased appetite, muscle twitching, and dyskinesia.
4.9 Overdose
Management of overdose
Management of overdose should concentrate on supportive therapy, maintaining an adequate airway, oxygenation and ventilation, and management of symptoms. The possibility of multiple medicinal product involvement should be considered. Therefore cardiovascular monitoring should be started immediately and should include continuous electrocardiographic monitoring to detect possible arrhythmias. Following any confirmed or suspected overdose with aripiprazole, close medical supervision and monitoring should continue until the patient recovers.
Activated charcoal (50 g), administered one hour after aripiprazole, decreased aripiprazole Cmax by about 41 % and AUC by about 51 %, suggesting that charcoal may be effective in the treatment of overdose.
Although there is no information on the effect of haemodialysis in treating an overdose with aripiprazole, haemodialysis is unlikely to be useful in overdose management since aripiprazole is highly bound to plasma proteins.
for more information: https://www.medicines.org.uk/emc/product/7969/smpc
Write a review
Your Name:Your Review: Note: HTML is not translated!
Rating: Bad Good
Enter the code in the box below:


text:
Novikov Restaurant & Bar
London, UK
Part of the eponymous global Russian restaurant group, Novikov is a place to see and be seen. Separate Italian and Asian dining rooms offer extensive options from dim sum to sushi, pasta to steak. This is food to be shared. On the Asian side, hosts can impress with sashimi platters, king crab legs and even Peking duck pancakes with caviar, while on the Italian side there are showy dishes such as tonnarelli served in a wheel of Parmesan. But the food is just the beginning – Novikov opens to the party crowd until the early hours in the downstairs Lounge Bar.
Key Information
- Average price per person $90
- Lunch and dinner: Mon – Sun
- +44 20 7399 4330
- Visit Novikov Restaurant & Bar's Website
50A Berkeley Street, Mayfair, London, W1J 8HA


text:
The zero-emissions system was installed by Adroit Solar / Energy / Design (www.adroitsolar.com), a leading San Diego designer and installation contractor of large-scale solar water heating systems and other renewable energy and energy efficient technologies for commercial and large residential properties. At this project they installed 3 separate systems consisting of 72 solar thermal collectors manufactured by Vaillant Solar Systems that will provide an estimated 3,800 gallons of hot water a day to the Mission Heights Condominiums that were built in 1979.
"Solar water heating is perfectly suited for condominiums and apartment buildings because a single system can supply the hot water needs for many residents at once, improving the efficiency and long-term sustainability of their buildings," said Irene Stillings, CCSE executive director. "The Mission Heights Homeowners Association has taken a significant step forward in reducing their energy use and helping to curb greenhouse gas emissions with clean solar energy."
"San Diego Gas & Electric (SDG&E) customers will benefit from the efforts of this valuable program that will increase the amount of solar water heaters in the region," said Caroline Winn, vice president of customer services for SDG&E. "This means lower energy bills and carbon footprints for our customers."
"In just six months we have already saved thousands of dollars in water heating costs. Comparing utility billings from January through June 2010, with utility billings for the months of January through June 2011, we have saved $3,800," Aaron Sathrum, President of the Mission Heights Homeowners Association, said. "Due to the attractive energy savings, and the CSI thermal rebate program, solar water heating was a good financial decision for the homeowners association. It will help keep our dues low for many years and increase property values now and into the future. Every homeowners association should strongly consider installing solar thermal systems for their residents."
"Our hats are off to Mr. Sathrum for taking the time to investigate and understand the environmental benefits of adopting this technology and the significant financial savings for the homeowners at Mission Heights," said David Demarest, business development manager at Adroit Solar / Energy / Design.
Obstacles to Overcome:
"Part of the reservations many homeowners, business owners and some contractors have about the actual costs to implement these types of energy saving technologies are due to their lack of familiarity with the rebates now available through the California Solar Initiative Thermal Program and Federal Tax Credits, Bonus Depreciation nor how to fully utilize them – it is a somewhat complex process," Demarest said. "Once shown the actual costs to implement these technologies, after rebates, tax credits and depreciation are taken into consideration, making the decision to adopt them is very easy because it is financially logical. After the Federal Tax Credit or Grant, CSI Thermal incentive and Bonus Depreciation the cost of a system can be less than 10% of the gross cost. It should be noted that without the rebates and incentives offered by the CSI Thermal program of $12.82 per therm saved, the 30% Federal Tax Credit and Depreciation, many of these projects would not be undertaken by property owners; we are all fortunate in California to have access to these programs."
Recently Completed Projects:
Of the several recently completed commercial / multifamily solar water heating installations by Adroit Solar, Hill 'N Dale Townhomes in San Diego installed a system consisting of 90 Vaillant solar collectors generating 151 kWthermal, providing 3,370 gallons per day, displacing 5,419 therms of natural gas and 127,080 pounds of CO2 a year. This multifamily solar water heating installation qualified for a $69,471 CSI incentive from CCSE. Cantabria Condominiums solar thermal system consists of 120 Vaillant solar collectors generating 202 kW thermal, providing 4,416 gallons of hot water per day, displacing 7,983 therms of natural gas and 169,440 pounds of CO2 per year. This installation qualified for a $102,342 CSI-thermal incentive. "Solar Thermal is the original solar energy technology and is four times as efficient as Photovoltaics, kilowatt to kilowatt, in the same collector area. Solar Thermal is mature, robust and ready for mass adoption," says Jim Backman, founder and owner of Adroit Solar.
The California Public Utilities Commission established the statewide solar thermal rebate program in January 2010 to help reduce the up-front cost of solar hot water systems. CCSE administers the program in the San Diego Gas & Electric service territory. Rebates are available for almost all single-family homeowners to install solar water heating systems as well as certain commercial and multifamily applications.
Adroit Solar / Energy / Design is a San Diego renewable energy and energy efficient technology contractor with 25 years of experience in the solar energy. Adroit Solar installs solar photovoltaic, solar thermal, ground source geothermal heating and cooling systems, radiant heating and cooling systems, hydrogen fuel cells, microturbines and provides design and specification work for development of energy independent "net zero," high-end residential and commercial properties. They are a licensed contractor in California and Hawaii with C46 (solar) and C36 (plumbing) licenses, a member of the U.S. Green Building Council (USGBC). Owner and President James Backman is a LEED Accredited Professional (Leadership in Energy and Environmental Design), as are most of Adroit Solar employees. Adroit Solar / Energy / Design recently contributed to two San Diego Energy All-Star award winning projects and has processed more commercial solar thermal installation rebate submittals through the CSI rebate program than any other contractor in San Diego.
The California Center for Sustainable Energy (CCSE) is a nonprofit organization that helps individuals, businesses, municipalities and others to adopt greener practices and save energy and money through rebates, technical assistance and education. CCSE's Energy Advisory Service is a group of accredited engineers, energy raters and technical specialists who provide comprehensive expertise on a wide range of challenges related to energy efficiency, renewable energy, green building and carbon impacts.


text:
Volkswagen launched the new Polo on the Chinese market earlier this month. The new CrossPolo popped up at a Volkswagen even, it will be listed later this year. The CrossPolo is made in China by the Shanghai-Volkswagen joint venture.
Crossover cars are still very popular in China, sometimes even the best sellers of the line. The old CrossPolo sold in great numbers as well, the new car will no doubt do fine again. Price will start around 100.000 yuan. Via: 163.com.


text:
I make another would I date you (guys)
so... you're actually reading this? most people don't so I told you this in a question, I already made a would I date you but I thought I should make a new one
because I know I've changed a lot from just this past school year and yaaaaaa.. ughh they make me need so many words. just take the quiz now. ok. go.


text:
Cantwell Fights For Community Banks
Source: KUOW 94.9
The Democratic senator says the federal government should help community banks the same way it helped Wall Street.
Cantwell: "My reason for being persistent about this issue is that when the big banks were in trouble, we acted almost overnight to help them, without little question, without little oversight and without a general design. Now it's been more than a year after the crisis and we still don't have a program designed for small banks."
Cantwell supports President Obama's proposal to use $30 billion in TARP funds to help community banks lend to small businesses. However, she says the President should implement the plan immediately rather than waiting for Congress to act.
Cantwell pointed to Danny Mitchell as an example. Mitchell used to own and operate Mitchelli's, it's an Italian restaurant in Pioneer Square. After 32 years of business, he had to close his doors last year.
Basically, his lending dried up. Mitchell couldn't get a loan, and the only credit options left had real high interest rates.
Mitchell: "Ultimately, we kept falling further and further behind and the payment demands from the various taxing agencies became overwhelming and we just couldn't continue."
Laurie Stewart says community banks are having trouble extending loans because regulators are asking banks to hold more capital. She's the President and CEO of Sound Community Bank, based in Seattle.
Stewart: "If I could hold $1 of capital and lend $100 before, just as an example, that's not accurate. Now they're asking me to hold, like, $2 of capital."
That means banks can only grow their balance sheets so far.
Stewart: "We're really being constrained by either specific requirements from regulators in some cases or our fear of specific requirements from regulators that means that we're kind of hoarding that capital and making fewer loans as a result."
Stewart says TARP funds would help increase lending at her bank.
At a recent Senate hearing on small-business lending, Cantwell said making more credit available to small business should be a higher priority than more stimulus spending.
Next Article Previous Article


text:
Semiconductor detector days at CPPM
The "R & D instrumentation" network dedicated to semiconductor detectors (IN2P3-IRFU), created in 2012 with the aim of promoting exchanges between the various laboratories active in the field, is organizing two half-days, on 25 and 26 June 2019 at the CPPM (CNRS - AMU) on the theme of fast detectors and their associated electronics.
These days are primarily aimed at users of different semiconductor detectors (instrumentalist) wishing to discover and understand the latest associated technologies, their performance and limitations.
--> For more information : https://indico.in2p3.fr/event/18911/
Dernière modification: Apr 24, 2023, 9:28:03 AMEuclid Star Prize awarded to CPPM and IPNL teams
The characterization team's expertise is based on an early experience with IR detectors in the framework of the SNAP collaboration and expanded to the highest level within the Euclid project. The team members combine strong complementary skills: mechanical and thermal design of the bench, software development for acquisition and bench control & automation, instrumentation, test procedures of pixel detectors. Thanks to the close collaboration of CPPM & IPNL, the team has developed and validated dedicated test facilities of high quality and excellent running efficiency with a fully automated acquisition scheme. The characterization of the 20 IR detectors has taken over one year with 85% efficiency, leading to 400 TB of data from which the team will derive pixel map products and models for the SGS. The emphasis during these tests was the collection of data to enable the control of relative pixel gains, non-linearities, and persistence.
Dernière modification: Apr 24, 2023, 9:28:03 AM
The EPS High Energy and Particle Physics Prize 2019
The European Physical Society (EPS) has awarded the 2019 High Energy and Particle Physics Prize[1] to the CDF and D0[2] collaborations for their outstanding contributions to the discovery of the quark top and the precision measurements of its properties to date. . --> For mroe information :
[1] Prix EPS : https://eps-hepp.web.cern.ch/eps-hepp/ABCXYZprizes.php
[2] CDF et D0 sont des collaborations internationales d'environ 400 physiciens et techniciens chacune.
Dernière modification: Apr 24, 2023, 9:28:03 AMNectarCAM sees its first events of atmospheric cascades
The camera NectarCAM, equipped with its first 61 detection modules, saw its first events of atmospheric cascades in the sky of Berlin Adlershof, the night of 22 to 23 May 2019. She arrived on the site of the prototype MST (Medium Size Telescope ) May 16, 2019 from the CEA / IRFU to Saclay.
After the necessary ground checks, the camera was successfully loaded into the telescope by the IN2P3, CEA / IRFU and Desy Zeuthen teams. Close cooperation between all the teams of the NectarCAM consortium, not forgetting the telescope team, made it possible to carry out this first objective, which is essential for the project, before the on-site deployment at the end of 2020 in the Canaries.
The CPPM constructed the data acquisition system (event builder) using an innovative low cost approach.
Read more on : https://in2p3.cnrs.fr/fr/cnrsinfo/nectarcam-voit-ses-premiers-evenements-de-cascades-atmospheriques
Dernière modification: Apr 24, 2023, 9:28:03 AMFranco-Chinese summer school hosted by CPPM
At the initiative of the French Embassy in China and with the Campus France agency, France Excellence Summer Schools are offered every year throughout the country, in different research fields. The objective of this program is to improve the quality and quantity of recruitment of Chinese doctoral students in French universities. The Centre de Physique des Particules de Marseille (CNRS - AMU) and the Institut de Physique Nucléaire de Lyon (CNRS - Université Claude Bernard Lyon 1 - Université de Lyon) are jointly organising, as part of this programme, a summer school on the physics of the two infinites, from 1 to 11 July.
--> For more information : https://indico.in2p3.fr/event/18335
Dernière modification: Apr 24, 2023, 9:28:03 AM


text: Home Industry Finance Kuwait family businesses should join stock market – minister MSCI will add Kuwait to its main index tracking stocks in emerging markets in June 2020 by Bloomberg September 30, 2019 Family businesses in Kuwait should be encouraged to sell shares on the country's fledgling stock market, which is also trying to attract foreign investments in an effort to expand, according to a key minister. "We think we have the muscles, the know-how, and all the opportunity to become a commercial hub," minister of Commerce and Industry Khaled Al-Roudhan said in an interview. "We're trying to improve our business environment not only for foreigners but Kuwaitis too." Kuwait is working to help the exchange grow, Al-Roudhan said, touting upcoming IPOs, a "very ambitious" development programme by the Capital Markets Authority focused on accessibility for foreign investors, as well as the lack of foreign ownership limits. The Capital Markets Authority will start a public offering of its 50 per cent stake in Boursa Kuwait next month, making it the second publicly traded exchange in the Gulf after Dubai. "This will enhance its profile further and increase its competitiveness," according to Al-Roudhan. MSCI will add Kuwait to its main index tracking stocks in emerging markets in June 2020, once some trading mechanisms are improved, in an upgrade that has been priced in by investors anticipating billions of dollars of inflows. More high-profile listings can be gained by "speeding up the privatisation programme and public-partnership project implementation," Al-Roudhan said. The minister also said: * Foreign investments of $1.5bn entered as a result of the capital market upgrading to the EM category in the FTSE index * Approximately $2.5bn is expected after the official upgrade of MSCI * S&P Dow Jones's upgrade of Kuwait to an emerging market will encourage more foreign investment * Foreign direct investment under the Kuwait Direct Investment Promotion Authority reached $3.2bn between 2015 and March 2019 * Kuwait is creating a new path to bring more foreign investors to the area; six laws in the pipeline to help boost investment and commerce, including an insolvency law, import law and competition protection law * As part of a drive to open up the country and become a commercial and financial hub for region, Kuwait is working closely with Iraq to boost trade. A joint economic committee formed in 2014 met Sunday for the first time. "We think there's big room to improve the economic relationship with Iraq," Al-Roudhan said. "Our trade with Iraq in terms of numbers is below expectation. What we did with Iraq is try to separate political issues from the economic, I think this is a benefit to both countries." Under former president Saddam Hussein, Iraq invaded Kuwait in August 1990, occupying it for almost seven months before being ousted by a U.S.-led coalition. Both sides have signed a free-trade agreement and established a free-trade zone near the Safwan border, which Kuwait will finance and build. 0 Comments


text:
Dear Patients,
We hope this letter finds you and your family in good health. As COVID-19 cases continue to decline and our normal routines and habits resume, our commitment to your safety will remain.
Infection control has always been a top priority for our practice, and you may have seen this during your visits to our office. Our infection control processes are made so that when you receive care, it's both safe and comfortable. Please read about the infection control procedures we follow in our practice to keep patients and staff safe.
Our office follows infection control recommendations made by the American Dental Association (ADA), the U.S. Centers for Disease Control and Prevention (CDC), and the Occupational Safety and Health Administration (OSHA). We follow the activities of these agencies so that we are up to date on any new rulings or guidance that may be issued. We do this to make sure that our infection control procedures are current and adhere to each agency's recommendations.
Our current safety precautions include:
- Daily Bioblast Antiviral spray treatment of entire office
- Thoroughly disinfecting all surfaces
- Using a HEPA Air Purifier
- Hand sanitizer placed throughout the office
- UV air sanitizers placed directly onto our AC units
- All OSHA standards remain in place throughout the operatories where clinical procedures are performed
- Mask wearing for patients is optional; our clinical team always wears masks
- Patients are welcome to wait in their cars or in our waiting area
- Staff is no longer wearing extra PPE gear, only the required PPE
We look forward to seeing you again and are happy to answer any questions you may have about the steps we take to keep you, and every patient, safe in our practice. To make an appointment, please call our office at (239) 597-7333.
Thank you for being our patient. We value your trust and loyalty and look forward to welcoming you back to Massa Dental Center. We wish you continued safety and good health.
Dr. James Massa


text:
"To be put in a position where you're basically begging off people, it's infuriating."
Last October, 12-year-old Hayden Kildea was diagnosed with severe scoliosis, a condition where the spine twists and curves to the side. Left untreated, it can become a dangerous and life-limiting condition.
The Kildeas, who live in Strabane, Northern Ireland, say they were told Hayden would need urgent surgery – but that because of the backlog caused by the pandemic, he would have to wait more than two years.
His mum Shauna found a clinic in Turkey that was able to carry out the operation immediately, but it would cost £50,000 – money the family didn't have.
So in the summer, they turned to crowdfunding and campaigning to raise the money.
She says: "It's really, really frustrating that we're in our own country and we can't get Hayden the surgery he needs."
Millions of people across the UK are currently on NHS waiting lists – in Northern Ireland there are over 465,000 people, while in England, 5.6m are queuing for treatment.
Data shared with BBC Panorama shows that on average, waiting lists have grown by 50% in the most deprived parts of England since the start of the pandemic, compared with nearly 35% in the most affluent areas.
The research, conducted by the King's Fund, also shows that people on waiting lists in poorer areas are nearly twice as likely as those in wealthier areas to wait more than one year for treatment.
The data looks at waiting lists from April 2020 to July 2021 (the latest available data) and includes planned hospital treatments such as knee and hip replacements, cataract surgery and other common procedures.
Hayden Kildea's family reached their target. He has now had the operation in Turkey and is recovering back at home.
The Health and Social Care Board in Northern Ireland said patient demand continued "to exceed capacity across a range of specialties". It added: "As a result, even before the pandemic, the number of people waiting longer than the target waiting times was increasing."
Sofia Jones, 36, has endometriosis – a gynaecological condition that leads to severe pelvic pain. Some days she could barely walk, having to stay in bed all day.
Sofia, who lives near Dundee, says she was told she'd have to wait two years for an NHS operation. But that felt too long to wait, so she and her partner decided to take out a £7,000 loan to pay to have the surgery in a private hospital.
'It was a really tough decision to go private," she says, "because we were having to put ourselves into debt. And that's a lot of money. But you have to have some quality of life."
A Scottish government spokesman said: "We're sorry the unprecedented impact of the pandemic has lengthened waiting times for some patients. The pandemic has been the most significant challenge the NHS has faced in its 73-year history, and as in many health care systems across the world, the unavoidable pausing of non-urgent elective procedures has resulted in some delays."
According to Anita Charlesworth, chief economist at the Health Foundation think tank: "The big worry about long waits leading people to have to go private is that it will increase inequalities, but also that many people will be forced to make awful trade-offs over their finances in order to be able to get access to the care that they need when they need it.
"And that goes against every grain of why we set up the health service," she said.
Brenda Pugh, 61, from Petersfield in Hampshire, had to give up work in a law firm in 2019 after being diagnosed with arthritis. She was unable to work due to the pain caused by her arthritis which was first diagnosed five years ago.
As the pandemic began, she was told she needed a double hip replacement and now has to use crutches. When she moves she says it's like "walking on jagged glass".
The pain is so severe she has written to her consultant, begging him for the operation. She says: "I can't carry on like this. My life just isn't worth living."
The cost to have the surgery privately would be about £10,000 per hip – and she says there's no way she can afford that.
Brenda is one of 62,000 patients who've been waiting more than 12 months to get joint replacement surgery.
New research conducted by charity Versus Arthritis and given exclusively to BBC Panorama reveals that half (54%) of people with arthritis who are currently waiting for surgery are facing an average cost of £1,739 a year to keep their pain at bay, through things like private physio appointments and over-the-counter painkillers.
Inevitably, GPs are the ones patients turn to for help managing their pain as they wait. One of them, Dr Leora Harverd, from a practice in north London, says she's overwhelmed by her current caseload.
Some of her patients are anxious about long delays for treatment, and says it's not unusual that people go private, but "it's not how it should be".
This month the government announced they would be investing £36bn in NHS and social care for all four home nations up to 2025.
Analysis of their plans by the Health Foundation shows that £10bn has been committed to address the backlog in England over the next three years.
Ms Charlesworth says it's a lot of money but won't necessarily be enough: 'If we want the waiting list to come down by the next election, we would need to spend at least £13bn; if we wanted to meet the target to treat people within 18 weeks, we need to be spending £17bn – and the government has committed £10bn."
But even the prime minister has admitted that "waiting lists will get worse before they get better".
NHS England said: "Caring for more than 450,000 seriously ill Covid patients has inevitably had a knock-on effect on non-urgent care.
"NHS staff have stepped up and made effective use of additional resources helping carry out millions more tests, checks, treatments and operations this summer compared to last."
BBC Panorama – NHS: Wait or Pay is available on BBC iPlayer.
Source: Victoria Derbyshire, BBC
Additional reporting by Caroline Parkinson


text:
Regular price
Ban Sea Lions Decal White
Regular price
Ban Sea Lions Decal White
Salmon lives on our rivers are decreasing every year due to sea lions. Show your support of removing these animals with the Salmon Lives Matter Decal in Black or White.
Dimensions 6 1/2"
Fishing addicts does not support the illegal killing of seals or sea lions, but we are passionate about the fight to protect our salmon from these invasive animals. Show that you support the removal of these animals too!


text:
Which Is The Best 1970'S Home Decor
Nowadays, there are so many products of 1970's home decor in the market and you are wondering to choose a best one. You have searched for 1970's home decor in many merchants, compared about products prices & reviews before deciding to buy them.
You are in RIGHT PLACE.
Here are some of best sellings 1970's home decor which we would like to recommend with high customer review ratings to guide you on quality & popularity of each items.
Eraserhead Poster, the Man in the Planet, 1970's Horror Film, David Lynch
This is a brand new Eraserhead poster. It measures 13in x 19in and is printed on high quality paper. To ensure a safe delivery, posters will be rolled in a plastic sleeve and shipped in a protective shipping tube. Satisfaction Guaranteed!
Buyartforless Framed Pink Floyd Carnegie Hall New York May 1 1972 36×24 Music Art Print Poster
Framed pink Floyd Carnegie hall new York may 1 1972 36×24 music art print poster. Packaged to arrive in perfect condition. Image size: 36×24 – glass size: 36×24
54" Decorator Weight Perched Owls on Dark Brown Large-Scale Whimsical 1970's Retro Vintage-Look Home Decor Upholstery Fabric by The Yard (D791.17)
Home Decor Fabric – 54″ Wide – Sold by the yard – Combine other Fabrics from our store for shipping discount!
A16HYQ Garden Flags Worn-Out USA Flag Retro 1970's Style Sasquatch Welcome Large Yard Double Sided House Flag Banners for Patio Lawn Home Outdoor Decor 12.5x18In 28x40In
- FEATURES:Premium Polyester Material.Good Wrinkle Resistance,Universal For Four Seasons,Durable,Not Easy To Fade,Easy To Disassemble.Hand Washable Machine Washable.
- UNIQUE DESIGN:A Variety Of Interesting,Good-Looking Patterns.Suitable For Festivals,Parties,National Day,Anniversary Celebration,Celebration Parade,Etc.Our Durable Polyester Fabric Is With Bright And Vibrant Colors And Is Characterized By Premium Polyester Ultraviolet-Proof,Fade Resistant That Keep It Flying For Many Seasons.
- OUTDOOR GARDEN DECORATION:This Wonderful Little Flags Will Be Perfect For Hanging From Your Flag Poles,Adding Decor To Your Garden,Welcoming Guests To Your Front Door,or Greeting Family And Friends At Your Back Door.
- FLAG SIZE:12.5x18In,28x40In,Full-Width Printing,Double-Sided Printing Double Suture,Not Including Flag Stand.
- SHIPPING:7 To 15 Business Days,If You Have Any Questions,Please Sent Us The Email,We Will Help You As Soon As Possible.We Provide You The High Quality Outfit And The Best Service.
Add A Touch Of Your Personality And Welcome Guests Warmly To Your Home And Garden With This Decorative Flag.
The Garden Flag Is The Best House Decoration You Will Ever Find.It Immediately Catches The Attentions Of All Your Friends, Neighbors, Guests Or Anyone Who Walks By!
Great Gifts For Any Deck, Patio, Porch Or Veranda And Make Charming Decorative Statements For Any Backyard,Lawn Or Garden.
Whether It Is Fall,Winter,Spring,Or Summer,Our Flags Are Resistant To Any Amount Of Rain,Snow,Or Harsh Sunlight.It Will Outlast Your Neighbors' And Stay Vivid Forever!
1.Due To Different Display In Various And Shooting Light, There Might Be Some Color Difference Between The Picture And Product.
2.If You Have Any Questions, Please Sent Us The Email, We Will Help You As Soon As Possible.
3.This Is A Custom Product, You Can Make It Your Own By Sending Us Your Favorite Photos And/or Texts.
Katie Doodle Disco 70s Party Decorations Supplies Decor Centerpiece for 70's Theme | Includes Back in 1970 Sign [Unframed], Black Gold
- Get the best 70s party decorations or disco party decorations with this Back in 1970 sign designed exclusively by Katie Doodle
- This sign is the perfect conversation piece for any room! Your guests will love recalling popular 1970's events, movies, music and facts.
- Looking for 70s decorations or 70s decor? Well look no further! This sign is the perfect compliment to any 70s theme party decorations!
- Professionally edge printed on thick 8×10″ premium cardstock (unframed). Fits in any 8×10 inch frame!
- 100% MONEY BACK GUARANTEE – If you're not completely satisfied with your 70s party decorations you can return it for free. No questions asked!
This premium 8×10″ sign (unframed) will compliment any 70s party decorations or disco party decorations. Our "Back in" sign takes you back in time with fun facts and highlights of what happened in that year. Designed to give you a memorable and unforgettable event. Whether you are looking for 70s decorations, 70s decor, disco theme party decorations or 70's party decorations, this is the perfect sign for you.
Blue Nile Mills Ceará Shag Area Rug, Plush, Extra-Thick Pile, Shabby-Chic, Retro, Abstract, Bold Wave Design, Jute Backing, Black, 5′ x 8′
- STYLE: This retro rug features a bold and dominating wave design in eye-catching contrasting colors
- well-made with a sturdy jute backing
- will inspire many cups of coffee and inspiring conversation around
- SIZE: Versatile rug for under a coffee table, office, foyer, bedroom, or living room
- this charming soft wonder is available in runner size 2′ 7″ x 8′, 3′ x 5′, 4′ x 5′ 7″, 5′ x 8′, 6′ x 9′, and living room size 8′ x 10′
- EASY CARE: Shake and comb by hand
- do not vacuum on top as it may cause snag and matting
- flip the rug over and use the suction of your vacuum without the brush to get rid of debris
- your shag rug will have a fluffy makeover
- rug pad recommended
- GOOD TO KNOW: Shag rugs trace back to Ancient Greece in origin and rose to popularity in 1960's and 1970's in America
- hand-tufted to produce a thick lush pile comparable to animal fur in softness
- created with a tufting gun without knots or a loom
- 100% RISK FREE BUY: Our products are backed by loyal guest service to ensure your purchase is worry-free
- perfect gift ideas for house-warming, anniversaries, Christmas, bridal, Valentine's Day, and more
- complete satisfaction guaranteed
Add a splash of wave design with the Ceará Area Rug from Blue Nile Mills. The bold pattern of waves in bright and vibrant colors like red, black, beige, and white, will encourage a flow and movement of thought in you and make you happier. Its transcendental pattern has undertones of mystical and sublime, and has the potential to transform your ordinary space into an extraordinary space. Hand-tufted to be soft and supple to the touch, and ensuring long-lasting quality, this rug features a sturdy jute backing. Crafted for strength and durability in 100% Polyester fibers, indulge in the silky-smooth experience of this plush rug, with the generous pile height of 1.18″. Its OEKO-TEX certification ensures that it is completely free from harmful chemicals and safe for human use. We recommend this rug be used more decoratively with a rug pad, and in low traffic area. Impress your family and friends simply by making this shag rug a part of your lovely home.
Similar items with 4 stars and above
Retro 1970's Style Snowboarder Silhouette Snowboard Indoor/Outdoor Banner 100% Polyester Flag Garden Flag 3×5
Decor: In Courtyard, Garden, Flowerpot, Wedding Party And Anniversary Decor, Opening Ceremony, On The Wall.Makes An Excellent Gift For Friends, Parents Or To PROUDLY Display On Your HOME.
60's Theme Party Decorations, Groovy Sign 60's Party Scene Setters Wall Decoration 60s Photo Backdrop Banner with Rope for Hippie Theme Groovy Party, 72.8 x 43.3 Inch
- 60s Groovy party backdrop design style: guitar, flower, rainbow, groovy sign and more 60's theme elements as picture show are full of energetic, they will highlight your groovy party style, let your families and friends enjoy much
- Applications: this 60s photo backdrop banner will add more retro party atmosphere, its bright color goes well with most 60's theme party, friends gathering, festivals and holidays
- 60's Theme backdrop size: approx. 185 x 110 cm/ 72.8 x 43.3 inches, this 60's theme banner is big enough to decorate your party and shown nicely in photos
- Durable material: the backdrop banner is made of polyester fiber fabric, it touches soft, smooth and it is durable enough for long time use, fabric material is also washable and fordable for easy storing
- Easy to use: the party backdrop banner is large, nice to decorate indoors or outdoors party activities, use 20 ft/ 6 m white rope (package included) can easy to pass through the copper buckle and hang it up
CafePress I Love The 70'S Oval Sticker Oval Bumper Sticker, Euro Oval Car Decal
- Express yourself with the design that fits your sense of humor, political views, or promotes your cause and beliefs.
- Our high quality bumper sticker is printed on durable 4mil vinyl with premium inks that resist the sun and elements, so your message will last for the long haul.
- These car decals are the perfect indulgence for your passion, or make great novelty prank gifts for him or her.
- Choose between Clear and White vinyl (where available). Size measures 3″x5″ for Small, 4.5″x7.5″ for Large. IMPORTED.
- We offer 100% money back guarantee, so you can buy with confidence. Your satisfaction is our promise, and returns/exchanges are made easy.
Tell the world how you feel with this sticker! Printed on quality 4mil vinyl with premium inks that are durable against the sun and elements, our stickers are perfect to use as a bumper sticker, window decal, or on your fridge. Speak your mind with this car decal on your work cubicle, school locker or bike, or have some fun giving it as a novelty gift. With CafePress, your satisfaction is always our promise…buy with confidence, as we offer easy returns and exchanges and a 100% money back guarantee.
(25) 7" Vinyl Records for Crafts & Decoration
This is a pack of 25 genuine 7″ 45 rpm records, a mixed lot, naked without sleeves. They are the standard "7 inch" records. Every item in this pack is a genuine vintage record from approximately the 1950s to the 1990s. Many are scarce. These records are categorized as 'craft grade,' meaning that they are meant for decoration or repurposed use, and not actual playing: they have more scuffs or scratches than is desirable for playing, maybe some edge chips, some of the labels are scuffed or mostly gone, the labels have extra stickers, or they are very common releases. They are excellent for craft and hobby use. (While many have skips or scratches, many are probably still perfectly playable on a record player!) Use them for projects, for business or home decor, for parties, and more!
By our suggestions above, we hope that you can found 1970's home decor for you.Please don't forget to share your experience by comment in this post. Thank you!


text:
Spanish – An Associated Press (AP) investigation revealed how China chose not to provide crucial information regarding the initial coronavirus outbreak. The World Health Organization (WHO) insisted – privately, never publicly – that China provide the specific data they had, but the request was unsuccessful.
It all started in that first week of January when many – if not most people – thought that COVID-19 was nothing serious. A simple flu although there were informal and unofficial reports from Wuhan that warned of a new and aggressive disease that was severely damaging the human respiratory system.
Contrary to what is popularly believed, the Chinese health authorities were quick to detect the virus and managed to decipher the genetic map in record time. Previous experiences with other similar diseases (severe acute respiratory syndrome in 2002) were likely helpful.
China had everything it needed to alert and inform the world about a new disease. It just had to be transparent, ask for cooperation, and let the WHO do its job. Well, as is evident now, the opposite happened. China hid and restricted vital information about the coronavirus, and the WHO, despite knowing this, decided to turn a blind eye.
The Chinese regime's non-transparency, and the WHO's complicity
According to AP, dozens of interviews, sources, and documents from their investigation determined that the Chinese regime withheld the publication of the genetic map or genome of the virus for over a week. This is due to the tight controls and restrictive measures that the Communist Party imposes on government laboratories. AP also points out controls on competition within China's public health system played a key role in the retention of data on the coronavirus.
The genome finally became public only on January 11, a week after government laboratories had already completely deciphered it. It was released only after the picture was leaked on a virologist website. While this was happening, WHO focused on emphasizing the "great response" of the Chinese regime to determine the real danger of the virus, knowing that they were hiding data and results.
Officials from the World Health Organization itself commented in private meetings on strategies to put pressure on China "without causing inconvenience to the authorities." The AP investigation shows that the main fear was that, if the WHO made public the regime's actions and asked for the information directly, the Chinese authorities could retaliate and hide what they knew. Which they did for most of January.
So, WHO not only failed to get quick and accurate information but has now shown that it was irresponsible and complicit.
The AP report itself reveals that, after the problem of transparency with the genome, China took up to two weeks to submit detailed data and reports to the WHO on cases and patients with the disease. Still, the organization's praise for China continued. The Donald Trump administration accused the World Health Organization of acting as a spokesman for the Chinese Communist Party and being a "puppet of China."
A compelling case is the one raised on January 3. According to the Chinese newspaper Caixin, the National Health Commission of China issued a confidential notice to the laboratories ordering them to destroy the virus samples, or alternatively, send them to authorized institutes for safekeeping. The order prohibited laboratories from publishing the genetic sequence or warning of the potential danger of the disease.
The fact is that the delayed publication of the genetic map made it difficult to determine the actual extent of spread to other countries, along with the development of tests, drugs, or vaccines on a global scale. The dearth of accurate patient data also made it difficult to determine how fast the virus was spreading, which was critical to stopping the epidemic.
China frustrated the WHO
"We are going on very minimal information," said American epidemiologist Maria Van Kerkhove, WHO's technical lead for COVID-19. "They are giving it (the information) to us 15 minutes before it appears on CCTV (China Central Television)," said Dr. Gauden Galea, WHO's top official in China.
This latest controversy is not the first involving China and the WHO, but simply a confirmation of a timely and revealing fact that would explain many doubts about the management of the initial outbreak of the pandemic.
The following are some of the irregularities between China and the WHO that came to light during this time: 1. Taiwan sent an email to the WHO in December warning of a respiratory disease coming from Wuhan, China (COVID-19). 2. A recent German intelligence report accessed by Der Spiegel magazine indicates that on January 21, Chinese President Xi Jinping asked WHO Director Tedros Adhanom in January to delay his warning about the threat and danger posed by COVID-19. The WHO denied this accusation. 3. The allegations by senior WHO officials that China was torpedoing the organization's investigations 4. The threats and actions taken by China against Australia because the latter called for an independent investigation into the initial handling of the disease. Australia's move affected the Chinese regime negatively because more than 116 countries subsequently joined the Australian request.
The World Health Organization constantly contradicted its coronavirus health recommendations. While Taiwan knew that the use of masks is essential, the WHO said that they should not be used. Similarly, the same organization said that "extreme measures," such as closing borders or restricting or banning flights from China, should not be overdone. Further, the WHO also said "there was no evidence" to determine that the virus was transmitted between humans, according to "preliminary investigations by Chinese authorities."
Preliminary investigations conducted by the Chinese authorities have found no clear evidence of human-to-human transmission of the novel #coronavirus (2019-nCoV) identified in #Wuhan, #China??. pic.twitter.com/Fnl5P877VG
— World Health Organization (WHO) (@WHO) January 14, 2020
Ali Mokdad, a professor at the Institute for Health Metrics and Evaluation at the University of Washington, told AP, "it is obvious that we could have saved more lives and avoided many, many deaths if China and the WHO had acted faster." However, it should be noted that Professor Mokdad also said that a more aggressive stance by the WHO could have triggered a more defensive stance by China and much less cooperation.
Lack of transparency led to deaths
The period of concealment and secrecy regarding the coronavirus led to the disease spreading around the world. The lost time translated into widespread proliferation, massive contagion, collapsed health systems, stagnant economies, and of course, deaths. China could have alerted the world, but it did not want to. The WHO could have exposed the regime and asked for the support of the vast majority of countries, but it preferred silence. After all these revelations, it is clear that the Chinese Communist Party, with its lies, and the World Health Organization, with its complicity, are directly responsible for the death of thousands.


text:
Eriez has improved standard offerings in its Suspended Permanent Magnet line. CP-20 and TP-25 Suspended Magnets, which have been successfully used in the recycling and aggregates industries in Europe for years, are now available in North America. These models replace the company's previous SP-6000 Magnets and provide a better price point, expedited delivery options and the same high performance.
CP-20 Series Magnets utilize a single-pole permanent magnet circuit to provide a uniform field across the feed belt to optimize separation efficiency of damaging tramp iron. These reliable, low-cost suspended magnets have a maximum suspension height of 10 in. and are available in both manual and self-cleaning configurations.
TP-25 Series Magnets utilize a twin-pole permanent magnet circuit to provide maximum ferrous removal at higher suspension heights. The twin-pole magnetic circuit used by the TP Series Magnets allows for horizontal lift of longer ferrous objects, such as rebar or wire. This results in improved ferrous removal and longer life for the self-cleaning belt. These suspended magnets have a maximum suspension height of 12 in. and are available in both manual and self-cleaning configurations.
The self-cleaning versions of both the CP-20 and TP-25 Series Magnets are available with either a standard electric drive or a hydraulic drive.
Eriez, http://erieznews.com/nr499


text:
Former Major League Baseball player, Otis Nixon, was seen leaving his Woodstock, Ga. home on the morning of April 8, 2017. The last time anyone saw the 58-year-old, he was driving a 2011 gray Range Rover.
According to WSB-TV, Nixon was driving to a golf course nearby wearing "a black long sleeve-shirt, black sweatpants and a black baseball cap, with black Adidas shoes with white stripes," but he never made it for tee time. Nixon's girlfriend called the Woodstock Police Department on Sunday afternoon to report that he was missing. Authorities had asked the public as well as the media to help locate this popular former athlete.
Nixon's career history
Otis Nixon played for several different teams during his 17-year career as a Major League Baseball player. According to the New York Post, "Nixon was a longtime switch-hitting outfielder, best known for his two stints with the Braves. He came up with the Yankees, playing his first 13 games with the Bombers in 1983, while also spending time with the Indians, Expos, Red Sox, Blue Jays, Dodgers and Twins." Even though Nixon scored 878 runs, and his batting average was .270, he was never asked to play in an All-Star Game. He also played for the Atlanta Braves starting in 1991, and according to the AJC, "was a key player in the worst-to-first season."
Nixon's drug abuse history
While Nixon was playing for the Atlanta Braves, he was suspended in 1991.
A drug test showed that there was cocaine in his system, which ended up causing him to not be able to play in the World Series that year. Throughout the years, Nixon had a few encounters with the police. He has been found in possession of drugs, as well as under the influence of drugs. According to the New York Post, "Nixon retired after the 1999 season, and was last in the headlines in 2013, when he was arrested for possession of crack cocaine." Police say that they retrieved another pipe in Nixon's truck, but Nixon claimed that the pipe belonged to his son.
Police are not releasing where Nixon was found
Nixon was found on Monday, April 10, 2017 after he was missing for approximately two days. According to CNN, Woodstock Police said, "Otis Nixon has been located and is safe. We appreciate the assistance from the public and media." At this time, the Woodstock Police Department is not releasing any information about where they located the former Major League Baseball player, or any other details about his mental state at the time he was found. Fans are relieved that Nixon is safe.


text:
After six months of being on full breast milk or formula milk feeds, your baby's body weight should have doubled. At this point of time, you can start to introduce him or her to the exciting world of food!
Singapore Health Promotion Board (HPB) recommends weaning to start at 6 months. Weaning is essential as full breast milk or formula milk will no longer be adequate to provide all the nutrients that he or she needs for growing. You may wonder how to commence or what to give as a start, especially if you are weaning your first born.
How do you know if your baby is ready? There are some signs that you can look out for:
- Around 5-6 months (Doubled birth weight)
- Milk isn't adequate anymore
- Watches you eat
- Sits with support
- Good neck strength
- Puts hands or toys into mouth
Giving the first food can be daunting, so it should not be complicated. Safe and recommended first food can be:
- Rice cereals, followed by
- Single ingredient vegetable/fruit puree such as carrot, pumpkin, potato, sweet potato, apples and pears.
Preparation can be easy and hassle free. You can choose to make it in bulk and freeze it, or prepare it on a daily basis. You may splurge on equipment to help you blend the baby food well, but the usual kitchen apparatus works just as well too.
Things you may need for food preparation:
- Clean cutting board and knife
- Pots and pot stand
- Sieve
- Spoons/forks
- Ice-cube tray (preferably with cover)
Steaming is the easiest way to cook these first foods thoroughly and healthily. After cooking, use a spoon to mash up food through the sieve until it reaches a smooth consistency. It is alright to store it in a thicker consistency because you can dilute it to a runny consistency with breast milk or formula milk just before feeding.
You can start with 1-2 teaspoons of rice cereals in runny consistency that's similar to formula milk. As your baby adapts to eating off a spoon, you can gradually increase the quantity of rice cereal per seating up to about 5 tablespoon or as recommended. Similarly for the pureed fruits or vegetables, start off with 1 ice-cube per feed and gradually increase at a pace that your baby is comfortable with.
Feeding apparatus you may need is simple:
- Comfortable, supportive chair
- Soft tip spoon
- Bib
- Wet towel
- Small, non-breakable bowl/plate
- Food warmer (optional)
Appropriate time and conducive setting is essential to enhance the weaning process:
Time | Environment |
Any time of the day as long as…
Every baby is different and will develop at their own pace. If your baby rejects a certain food, be patient and do not force feed. Try out the same food again at another sitting.


text:
Up a level |
Pavan, Giovanni Maria and Monteagudo, Silvia and Guerra, Javier and Carrion, Blanca and Ocana, Vanessa and Rodriguez-Lopez, Julian and Danani, Andrea and C Perez-Martinez, Francisco and Cena, Valentin (2012) Role of generation, architecture, pH and ionic strength on successful siRNA delivery and transfection by hybrid PPV-PAMAM dendrimers. Current Medicinal Chemistry, 19 (29). pp. 4929-4941. ISSN 1875-533X